Paula M. Castano, MD, MPH

Board Certifications: 
Gynecology, Obstetrics and Gynecology
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Hysteroscopic Tubal Occlusion, Pregnancy Termination, Routine Gynecologic Care, Contraceptive Care, Colposcopy, Intrauterine Device (IUD) Insertions, Menstrual Disorders, Tubal Ligation

Academic Appointments

  • Associate Professor of Obstetrics & Gynecology at CUMC

Administrative Titles

  • Medical Director, Outpatient Services
  • Medical Director, Columbus Circle Practice
I am proud to support my patients in making the reproductive health decisions that are right for them.

Paula Castaño, MD, MPH, is a board certified obstetrician gynecologist. She received an undergraduate degree at Brown University and completed medical school at the University of Minnesota. She was a resident at the University of Texas Southwestern Parkland Memorial Hospital in Dallas. Dr. Castaño completed her fellowship in family planning at Columbia University Medical Center, where she also obtained a Master of Public Health in Epidemiology. Her clinical focus is on office-based procedures. Her research interests include contraceptive use by HIV-infected women, the folate status of reproductive-aged women, and the use of technology to improve contraceptive continuation. She serves as director of the Faculty Practice.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Spanish

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-9368

Location(s)

ColumbiaDoctors Columbus Circle
1790 Broadway
New York, NY 10019
Primary
CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
CUMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
New York, NY 10032
NewYork-Presbyterian/The Allen Hospital
5141 Broadway
New York, NY 10034

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Minnesota Medical School
  • Residency: University of Texas Southwestern Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Gynecology
  • Obstetrics and Gynecology

Honors & Awards

  • Organon Inc. Resident Research Award Outstanding Research in Women’s Health

Research

Grants

AN OPEN-LABEL, NON-RANDOMIZED, PROSPECTIVE OBSERVATIONAL COHORT STUDY TO ASSESS POST-PROCEDURAL OUTCOMES IN TWO COHORTS OF WOMEN WHO CHOSE TO UNDERGO EITHER HYSTEROSCOPIC STERILIZATION (ESSURE) OR LAPROSCOPIC TUBAL STERLIZATION (P&S Industry Clinical Trial)

Nov 15 2017 - Nov 15 2022

PILOT BI-LATERAL TUBAL OCCLUSION TRIAL FOR FEMALE PERMANENT CONTRACEPTION (P&S Industry Clinical Trial)

Mar 8 2017 - Mar 8 2022

CLINICAL EVALUATION OF LONG-ACTING REVERSIBLE CONTRACEPTIVES (Federal Gov)

Sep 25 2015 - Jul 31 2020

A SINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE 3 STUDY OF THE CONTRACEPTIVE EFFICACY, SAFETY AND TOLERABILITY OF THE AG200-15 TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM (TCDS) (P&S Industry Clinical Trial)

Dec 16 2014 - Dec 16 2019

A MULTI-CENTER, MULTI-NATIONAL CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE ESSURE? (MODEL ESS505) DEVICE TO PREVENT PREGNANCY IN WOMEN WHO ARE SEEKING PERMANENT CONTRACEPTION (P&S Industry Clinical Trial)

Mar 11 2014 - Mar 11 2019

A PHASE III, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED, MULTI-CENTER TRIAL TO STUDY THE CONTRACEPTIVE EFFICACY AND SAFETY OF THE COMMERCIAL BATCH OF ORAL TABLESTS OF MK-8175A (NOMEGESTROL ACETATE 17BESTRADIOL) (P&S Industry Clinical Trial)

Feb 14 2013 - Feb 14 2018

COLUMBIA UNIVERSITY CISA CENTER (Federal Gov)

Sep 27 2012 - Sep 26 2017

A RETROSPECTIVE EVALUATION OF WOMEN UNDERGOING MIRENA INSERTION THROUGHOUT THE MENSTRUAL CYCLE (Private)

Feb 15 2013 - Aug 15 2014

TEXTFLUENZA: USING TECHNOLOGY TO PROMOTE FLU VACCINATION IN UNDERSERVED MATERNAL AND CHILD POPULATIONS (Federal Gov)

Feb 1 2010 - Jan 31 2014

PRENATAL BLOOD TEST FOR FETAL ANEUPLOIDY DETECTION (PROTOCOL TDX-002) (Private)

Dec 14 2010 - Dec 31 2012

CONTRACEPTIVE EFFICACY EVALUATION OF THE PATH FEMALE CONDOM (Federal Gov)

Sep 30 2009 - Dec 31 2012

OB GYN FAMILY PLANNING PASSTHRU (NY State Gov)

Jan 1 2009 - Dec 31 2012

MUSIC AS AN AUXILIARY ANALGESIC AND ANXIOLYTIC DURING FIRST TRIMESTER ABORTION (Private)

Jun 1 2009 - Jun 30 2011

AFFINITYHEALTH GRANT (P&S Industry Clinical Trial)

Aug 1 2007 - Sep 30 2010